生検装置の世界市場:企業動向

◆英語タイトル:Biopsy Devices - Current and Future Players
◆商品コード:GDME1050FPR
◆発行会社(調査会社):GlobalData
◆発行日:2016年4月1日
◆ページ数:※お問い合わせください。
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,500 ⇒換算¥399,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,385 ⇒換算¥613,890見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD8,300 ⇒換算¥946,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
【レポートの概要】

Biopsy Devices – Current and Future Players
Summary

Cancer is the uncontrolled growth of abnormal cells in the body. It can either spread to neighboring tissues or remain localized. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient’s body.

The biopsy devices market is segmented by cancer indication and by the type of biopsy procedure performed. This report provides up-to-date information and in-depth analysis of the key players that shape the global biopsy devices market. The report includes analysis of company profiles, industry trends, and corporate strategy.

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

- What are the procedure volumes for different biopsy procedures in different countries? How will the volumes change in the next five years?
- Growth in the biopsy devices market is driven by an increasing number of cancer incident cases. What are the current numbers of cancer diagnosed cases in different geographies? How will the numbers change in the upcoming years?
- Biopsy guns are most frequently used biopsy devices and core needle biopsy devices gain popularity over fine needle aspiration devices. What are the current adoption trends of different types of biopsy device in different geographies? How will the adoption trends evolve in the near future?
- There are various types of biopsy devices and different companies have a different strategic product focus. Who are the leading players in the biopsy devices market?

Reasons to buy

- “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Executive Summary
2.1 Market Dynamics
2.2 Key Players in the Global Biopsy Devices Market
2.3 Future Growth
2.4 Future Outlook
2.5 What Do Physicians Think?
3 Introduction
3.1 Overview
3.2 Catalyst
3.3 Related Reports
4 Industry Overview
4.1 Types of Biopsies
4.1.1 Surgical Biopsy
4.1.2 Fine Needle Aspiration
4.1.3 Core Needle Biopsy
4.1.4 Vacuum-Assisted Biopsy
4.2 Market Access to Cancer Screening Programs
4.2.1 Regulation
4.2.2 Biopsy Device Adoption Patterns
4.2.3 Reimbursement Trends
4.2.4 Regulatory Issues/Recalls
4.3 Mergers and Acquisitions/Key Partnerships
4.3.1 Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery
4.3.2 Argon Medical Devices Acquires Promex Technologies
4.3.3 GTCR Sells Devicor Medical Products
4.3.4 Becton Dickinson Completes Acquisition of CareFusion
4.4 Economic Impact of Cancer Screening and Treatment
4.5 Additional Indications for Biopsy Devices
5 Unmet Needs and Market Opportunity Analysis
5.1 Overview
5.2 Minimise Prostate Biopsy Complications
5.3 More Efficient Screening Tests for Cancer
5.4 More Efficient Screening Guidelines for Thyroid Cancer
5.5 Less Invasive Screening Tests With Better Accuracy
6 Competitive Assessment
6.1 Company Share Analysis
6.1.1 Vacuum-Assisted Biopsy Market Share
6.1.2 Core Needle Biopsy/Fine Needle Aspiration Market Share
6.2 Classification Based on System
6.2.1 Vacuum-Assisted Biopsy Devices
6.2.2 Core Needle Biopsy Devices
6.2.3 Fine Needle Aspiration Devices
6.3 Major Players
6.3.1 Argon Medical Devices
6.3.2 Becton, Dickinson and Company
6.3.3 Boston Scientific
6.3.4 Cook Medical
6.3.5 C. R. Bard
6.3.6 Gallini Medical Devices
6.3.7 Hologic
6.3.8 Leica Biosystems
6.3.9 Stryker
6.3.10 TSK Laboratory
6.3.11 Zamar Care
6.4 Pipeline Products Assessment
6.4.1 Overview
6.4.2 Optical Biopsy
6.4.3 Liquid Biopsy
6.5 Emerging Players
7 Market Outlook
7.1 Market Drivers and Barriers
7.1.1 Market Drivers
7.1.2 Market Barriers
8 Appendix
8.1 Bibliography
8.2 Abbreviations
8.3 Report Methodology
8.3.1 Overview
8.3.2 Coverage
8.3.3 Primary Research
8.3.4 Secondary Research
8.3.5 Forecasting Methodology
8.4 Key Opinion Leaders Included in This Study
8.5 About the Authors
8.5.1 Yizhe Xu, MSc, Research Analyst, Medical Devices
8.5.2 Linda Tian, MSc, Managing Analyst, Medical Devices
8.5.3 Tyler Fletcher, Global Head of Medical Devices
8.6 About GlobalData
8.7 Contact Us
8.8 Disclaimer

1.1 List of Tables
Table 1: Overview of Global Biopsy Devices Market*, 2015 and 2022
Table 2: VAB, Global Market Share, 2015
Table 3: CNB/FNA, Global Market Share, 2015
Table 4: Company Profile – Argon Medical Devices
Table 5: Argon Medical Devices, SWOT Analysis, 2016
Table 6: Product Portfolio – Argon Medical Devices
Table 7: Company Profile – BD
Table 8: BD, SWOT Analysis, 2016
Table 9: Product Portfolio – BD
Table 10: Company Profile – Boston Scientific
Table 11: Boston Scientific SWOT Analysis, 2016
Table 12: Product Portfolio – Boston Scientific
Table 13: Company Profile – Cook Medical
Table 14: Cook Medical, SWOT Analysis, 2016
Table 15: Product Portfolio – Cook Medical
Table 16: Company Profile – C. R. Bard
Table 17: C. R. Bard, SWOT Analysis, 2016
Table 18: Product Portfolio – C. R. Bard
Table 19: Company Profile – Gallini Medical Devices
Table 20: Gallini Medical Devices SWOT Analysis, 2016
Table 21: Product Portfolio – Gallini Medical Devices
Table 22: Company Profile – Hologic
Table 23: Hologic SWOT Analysis, 2016
Table 24: Product Portfolio – Hologic
Table 25: Company Profile – Leica Biosystems
Table 26: Leica Biosystems, SWOT Analysis, 2016
Table 27: Product Portfolio – Leica Biosystems
Table 28: Company Profile – Stryker
Table 29: Sktryker SWOT Analysis, 2016
Table 30: Product Portfolio – Stryker
Table 31: Company Profile – TSK Laboratory
Table 32: TSK Laboratory SWOT Analysis, 2016
Table 33: Product Portfolio – TSK Laboratory
Table 34: Company Profile – Zamar Care
Table 35: Zamar Care SWOT Analysis, 2016
Table 36: Product Portfolio – Zamar Care
Table 37: Emerging Players in Liquid Biopsy Market
Table 38: Age Demographics, Age >65 Years, Global, 2013

1.2 List of Figures
Figure 1: Composition of Global Biopsy Devices Procedures, 2015 and 2022
Figure 2 : Biopsy Devices, Global Market Share, 2015
Figure 3: VAB, Global Market Share, 2015
Figure 4: CNB/FNA, Global Market Share, 2015

【掲載企業】

Argon Medical Devices
Becton, Dickinson and Company
Boston Scientific
Cook Medical
C. R. Bard
Gallini Medical Devices
Hologic
Leica Biosystems
Stryker
TSK Laboratory
Zamar Care

★調査レポート[生検装置の世界市場:企業動向]販売に関する免責事項
★調査レポート[生検装置の世界市場:企業動向]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆